Document is current
Any future updates will be listed below
-
Authors
Russu, Alberto https://orcid.org/0000-0003-2095-4365
Hazra, Anasuya
Tian, Hui
Haddish-Berhane, Nahor
Perez Ruixo, Juan Jose https://orcid.org/0000-0001-9890-745X
Boulton, Muriel
-
Funding
Funding for this research was provided by:
Janssen Research and Development
- License Information
-
More Information
Article History
Received: 23 August 2024
Accepted: 6 January 2025
First Online: 28 February 2025
Declarations
:
: Alberto Russu, Hui Tian, Nahor Haddish-Berhane, Juan Jose Perez Ruixo, and Muriel Boulton are employees of Johnson & Johnson and report stock or ownership interests for Johnson & Johnson. Anasuya Hazra was an employee of Johnson & Johnson at the time of study conduct and is now affiliated with Regeneron, and reports stock or ownership interests for Johnson & Johnson.
: For the study data included in this PPK analysis, study protocols and amendments were reviewed by independent ethics committees or institutional review boards and were conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with International Council for Harmonization Guideline for Good Clinical Practices and applicable regulatory requirements. Patients or their legally acceptable representatives provided written informed consent to participate in the studies.
